Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Delve into Vironexis' launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in ...

Finding oneself at an advanced stage of disease is devastating and may diminish one’s hope for the future. Participation in a ...

Top-line results were announced from a phase 3 trial evaluating nerandomilast for the treatment of idiopathic pulmonary fibrosis.

US-based biotechnology company Trishula Therapeutics has reported positive results from its Phase I clinical trial of TTX-030 ...

HighField Biopharmaceuticals’ new immuno-oncology drug molecule HF1K16 shows safe and signals efficacy in treating refractory metastatic cancers: Hanghou, China Wednesday, Septe ...

A: The majority of inquiries are related to regulatory issues, such as the drug review process, and are classified as follows: investigational new drugs (16%), new drugs (13%), generic drugs (17% ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord ...